jama semaglutide Effect of Continued Weekly Subcutaneous vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial In a major new JAMA

SAFETY AND SIDE EFFECTS

Some individuals may find themselves reverting to old habits, which can counteract the benefits of semaglutide

[DOI] [PubMed] [Google Scholar] 21.Wang XF, Liu JJ, Xia J, Liu J, Mirabella V, Pang ZP

Clinical services are provided by third-party networks of U.S.-licensed clinicians who determine eligibility for GLP-1 treatment based on medical history and provider assessment

And people gain the weight back when they come off it. Costs for five of the GLP-1 drugs Ozempic, Mounjaro, Wegovy, Zepbound, and Saxenda topped $300 million for Boston-based Blue Cross last year, more than double what it spent in 2023